MARJAN
1.1.2019 14:55:10 CET | Business Wire | Press release
Ras Al Khaimah captivated the world with its 2019 New Year’s Eve Fireworks that welcomed hundreds of thousands of visitors to the emirate. Organised by Marjan, with the support of Ras Al Khaimah’s government entities, and put together by Fireworks by Grucci, the Ras Al Khaimah New Year’s Fireworks, spanning a duration of over 13.20 minutes, also clinched two Guinness World Records for the ‘Longest chain of fireworks’ and the ‘Longest straight line of fireworks’.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190101005028/en/
This year, the celebration was made even more memorable for the visitors with Al Marjan Island, the venue of the event and the flagship lifestyle destination by Marjan, hosting several family-oriented activities. Positioning the event on the global map of New Year’s Eve celebrations, the Ras Al Khaimah event was telecast internationally, and its images and videos shared on social media by millions more.
Eng. Abdulla Al Abdouli, Managing Director & CEO of Marjan, said: “The spectacular event highlighted the reputation of Ras Al Khaimah as the must-visit destination for celebrating the New Year’s Eve. With visitors arriving from across the world, the event served to highlight the touristic appeal of Ras Al Khaimah and to position it as a fast-growing leisure and commercial hub in the region. We thank the leadership of Ras Al Khaimah for their guidance and support in accomplishing this event, and all the government entities in the Emirate for the exceptional team work. With two Guinness World Records set, the 2019 Ras Al Khaimah New Year’s Eve Gala has been truly historic and adds to the pride of our nation.”
The celebration flagged off with a fascinating pyrotechnic tribute to the late Sheikh Zayed bin Sultan Al Nahyan, the founding father of the nation. In a befitting conclusion to the ‘Year of Zayed’ marked in 2018 to coincide with his birth centenary, the night-sky of Ras Al Khaimah came to life with a brilliant image of Sheikh Zayed followed by a magnificent fireworks display.
“With our tribute to the late Sheikh Zayed, we highlighted that his legacy and name is important for us – daily, every hour and every second of the day. For us, Zayed is the beginning of everything we do; Zayed is the start of every new challenge; Zayed is our sense of pride. And we are starting the year, once again, remembering and paying respect to our great leader,” said Eng. Al Abdouli.
The ‘Longest chain of fireworks’
Clinching the Guinness World Records for the ‘Longest chain of fireworks’, the first pyrotechnic display, the tribute to the late Sheikh Zayed, featured 11,284 firework devices. The earlier record was for deploying 10,005 firework devices set by Viejas Casino & Resort (USA) in Alpine, California, USA, on September 12, 2014. Fireworks were deployed from 52 sites along Al Marjan Island and the waterways of Ras Al Khaimah’s coastline, with the total length of the chain exceeding 4.6 kilometres. The show was designed to 12 international music compositions, and the record was set in just 40 seconds.
The ‘Longest straight line of fireworks’
This was followed drone countdown to the New Year. A canopy of golden showers followed, and Ras Al Khaimah won the Guinness World Records for the ‘Longest straight line of fireworks’. The stunning display spanned an area of 13 kilometres, trumping the earlier record set over a distance of 11.38 kilometres.
The display had the largest calibre of aerial shell at a diameter of 600 mm, the largest used in the UAE for any fireworks display during this New Year’s Eve. The record was set in 12.06 minutes, with fireworks positioned at 13 sites across Al Marjan Island and the waterways along the RAK shoreline. There were seven themed chapters for the show, which was set to international music compositions. The inspiration for the fireworks display was the natural beauty of Ras Al Khaimah, and it was choreographed to highlight the beautiful beaches and resorts along the Emirate’s shoreline.
SkyMagic Drone Show
A 200-piece SkyMagic drone show was precisely integrated into the fireworks design. Scenes such as the tribute to Sheikh Zayed were displayed within a 100m space in the sky accented by colourful bursts of fireworks. A sweeping display of a falcon spreading its wings emphasised the heritage of the Emirate.
Designed by Phil Grucci, CEO & Creative Director of Fireworks by Grucci, the event was verified by an official adjudicator from Guinness World Records for the ‘Longest chain of fireworks’ and the ‘Longest straight line of fireworks.’ Following the fireworks gala, Eng. Al Abdooli and Phil Grucci, received the Guinness World Records titles from the adjudicator.
Marjan worked closely with Ras Al Khaimah’s government entities including Ras Al Khaimah Public Works to create several public viewing areas across Al Marjan Island. More than 27,000 additional public car parking spaces were provided to welcome the guests.
Preparations for the 2019 Ras Al Khaimah New Year’s Eve Fireworks started in early 2018 immediately after the successful Guinness World Record achievement for the ‘Largest Aerial Shell’ displayed from Al Marjan Island at last year’s New Year’s Eve celebration.
Over 300 hours were spent to design the show. The design resulted in the programming of over 41,000 lines of computer instructions to control 20 computers to display the sweeping performance. The firework components for the aerial shells, ranging in size from 14 to 600 mm, were hand-crafted exclusively by Grucci in their factories in New York and Virginia over a two-month period.
This time, Marjan had added new viewing areas for more people to enjoy the show. Several family activities were hosted at the venue including food trucks, ice cream salons, lemonade corners, colourful band performances, and face painting and inflatable games for children. Stilt walkers, mime artists, and clowns welcomed the guests.
For more information, please visit: www.RAKNYE.com
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20190101005028/en/
Contact:
ASDA’A BCW Iman Ahmed | Anthony Fernandes | Ahmed Abdulrazek Tel: +97144507600 iman.ahmed@bcw-global.com anthony.fernandes@bcw-global.com ahmed.abdulrazek@bcw-global.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom